中文 | English
Return
Total: 475 , 1/48
Show Home Prev Next End page: GO
Author:(Jin-hui ZHENG)

1.3. 0-Tesla: opportunities and challenges.

Zheng-Yu JIN ; Hui YOU

Chinese Medical Sciences Journal 2006;21(4):205-208

2.The influence of nateglinide treatment of newly diagnosed patients with type 2 diabetes on the state of inflammatory response

Jin LI ; Hui YU ; Yonghong ZHENG

Chinese Journal of Primary Medicine and Pharmacy 2011;18(19):2605-2606

4.Repeated Administration of Newly Synthesized Aceclofenac Sustained Release Form Causes Agranulocytosis: Case Report of an Unforeseen Adverse Event during the Phase 1 Trial.

Hui JIN ; Renhua ZHENG ; Bohyung KIM ; Sung Vin YIM

Translational and Clinical Pharmacology 2014;22(1):11-12

5.Effect of peroxisome proliferator-activated receptor γ agonist on prostate epithelial cells

Lanbin ZHENG ; Yayuan ZHAO ; Wei YU ; Hui GUO ; Jie JIN

Chinese Journal of Urology 2010;31(1):52-55

8.Study of production of sesquiterpenes of Aquilaria senensis stimulated by Lasiodiplodia theobromae.

Xiao-Min HAN ; Liang LIANG ; Zheng ZHANG ; Xiu-Jin LI ; Yun YANG ; Hui MENG ; Zhi-Hui GAO ; Yan-Hong XU

China Journal of Chinese Materia Medica 2014;39(2):192-196

9.STUDY ON THE ANTIFUNGAL ACTIVITIES OF ENDOPHYTIC FUNGI ISOLATED FROM SEVERAL PHARMACEUTICAL PLANTS

Gui-Ling LI ; Jian-Feng WANG ; Yao-Jian HUANG ; Zhong-Hui ZHENG ; Wen-Jin SU ;

Microbiology 1992;0(06):-

10.Medium Optimization for Antitumor Agent Mycoepoxydiene by Marine Lignicolous Fungi Diaporthe sp.

Ruo-Yu WANG ; Yao-Jian HUANG ; Zhong-Hui ZHENG ; Wen-Jin SU ; Yue-Mao SHEN ;

Microbiology 1992;0(05):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 475 , 1/48 Show Home Prev Next End page: GO